PTGS1
Prostaglandin G/H synthase 1
Also known as: COX1, PGH1_HUMAN, PGHS-1, PTGHS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23219
- Gene
- PTGS1
- Ensembl
- ENSG00000095303
- Chromosome
- 9
- Canonical length
- 599 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Vesicles
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This is one of two genes encoding similar enzymes that catalyze the conversion of arachidonate to prostaglandin. The encoded protein regulates angiogenesis in endothelial cells, and is inhibited by nonsteroidal anti-inflammatory drugs such as aspirin. Based on its ability to function as both a cyclooxygenase and as a peroxidase, the encoded protein has been identified as a moonlighting protein. The protein may promote cell proliferation during tumor progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2021]
Canonical amino-acid sequenceUniProt
599 residues, UniProt reviewed canonical sequence.
>P23219|PTGS1
1 MSRSLLLWFL LFLLLLPPLP VLLADPGAPT PVNPCCYYPC QHQGICVRFG LDRYQCDCTR
61 TGYSGPNCTI PGLWTWLRNS LRPSPSFTHF LLTHGRWFWE FVNATFIREM LMRLVLTVRS
121 NLIPSPPTYN SAHDYISWES FSNVSYYTRI LPSVPKDCPT PMGTKGKKQL PDAQLLARRF
181 LLRRKFIPDP QGTNLMFAFF AQHFTHQFFK TSGKMGPGFT KALGHGVDLG HIYGDNLERQ
241 YQLRLFKDGK LKYQVLDGEM YPPSVEEAPV LMHYPRGIPP QSQMAVGQEV FGLLPGLMLY
301 ATLWLREHNR VCDLLKAEHP TWGDEQLFQT TRLILIGETI KIVIEEYVQQ LSGYFLQLKF
361 DPELLFGVQF QYRNRIAMEF NHLYHWHPLM PDSFKVGSQE YSYEQFLFNT SMLVDYGVEA
421 LVDAFSRQIA GRIGGGRNMD HHILHVAVDV IRESREMRLQ PFNEYRKRFG MKPYTSFQEL
481 VGEKEMAAEL EELYGDIDAL EFYPGLLLEK CHPNSIFGES MIEIGAPFSL KGLLGNPICS
541 PEYWKPSTFG GEVGFNIVKT ATLKKLVCLN TKTCPYVSFR VPDASQDDGP AVERPSTELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTGS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 228 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 228 nTPM
- skin: 144 nTPM
- colon: 102 nTPM
- esophagus: 63 nTPM
- fallopian tube: 41 nTPM
- rectum: 23 nTPM
Single-cell type
- platelets: 1,502 nCPM
- tuft cells: 795 nCPM
- endometrial luminal cells: 498 nCPM
- megakaryocytes: 284 nCPM
- mast cells: 220 nCPM
- smooth muscle cells: 174 nCPM
Immune cell
- basophil: 29 nTPM
- eosinophil: 23 nTPM
- total PBMC: 22 nTPM
- myeloid DC: 20 nTPM
- intermediate monocyte: 13 nTPM
- classical monocyte: 12 nTPM
Brain region
- white matter: 26 nTPM
- hippocampal formation: 16 nTPM
- thalamus: 15 nTPM
- spinal cord: 15 nTPM
- cerebral cortex: 14 nTPM
- medulla oblongata: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cyclooxygenase pathway
- long-chain fatty acid biosynthetic process
- prostaglandin biosynthetic process
- regulation of blood pressure
- regulation of cell population proliferation
- response to oxidative stress
Molecular functions
- heme binding
- metal ion binding
- oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
- peroxidase activity
- prostaglandin-endoperoxide synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTGS1 as an antibody target. Whether an autoantibody or antibody against PTGS1 could matter depends on whether native PTGS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTGS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTGS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...